LPL Financial
MTNB icon

LPL Financial’s Matinas BioPharma MTNB Stock Holding History

LPL Financial’s Portfolio MTNB Stock Details MTNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-816
Closed -$96.9K – 5253
2024
Q2 		$96.9K Hold
816
– – ﹤0.01% 4750
2024
Q1 		$166K Sell
816
-2
-0.2% -$356 ﹤0.01% 4545
2023
Q4 		$133K Sell
818
-5
-0.6% -$846 ﹤0.01% 4498
2023
Q3 		$80.3K Sell
823
-4
-0.5% -$737 ﹤0.01% 4457
2023
Q2 		$223K Sell
827
-20
-2% -$6.99K ﹤0.01% 4075
2023
Q1 		$298K Hold
847
– – ﹤0.01% 3747
2022
Q4 		$317K Buy
847
+20
+2% +$10K ﹤0.01% 3605
2022
Q3 		$394K Buy
827
+474
+134% +$279K ﹤0.01% 3361
2022
Q2 		$209K Sell
353
-1
-0.3% -$572 ﹤0.01% 3914
2022
Q1 		$214K Sell
354
-16
-4% -$8.83K ﹤0.01% 3799
2021
Q4 		$280K Hold
370
– – ﹤0.01% 3728
2021
Q3 		$361K Buy
370
+162
+78% +$105K ﹤0.01% 3497
2021
Q2 		$121K Buy
208
+4
+2% +$2.58K ﹤0.01% 4027
2021
Q1 		$160K Buy
204
+25
+14% +$25.2K ﹤0.01% 3834
2020
Q4 		$183K Buy
+179
New +$124K ﹤0.01% 3554

Other funds holding MTNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Highbridge Capital Management
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Sargent Investment Group
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
JTC Employer Solutions Trustee
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Sanctuary Advisors
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return

LPL Financial's MTNB Position: Q3 2024 in Review

LPL Financial sold out of Matinas BioPharma (MTNB) in Q3 2024, closing a stake of 816 shares — an estimated $96.9K sold.

LPL Financial first reported a position in MTNB in Q4 2020 and held it in 15 quarters. The position peaked at $394K in Q3 2022. 18 funds tracked by Wall St. Rank hold MTNB as of Q3 2024.

  • LPL Financial reported no remaining Matinas BioPharma position as of Q3 2024 after selling out during the quarter.
  • LPL Financial sold 816 Matinas BioPharma shares in Q3 2024, an estimated $96.9K.
  • LPL Financial first reported a position in Matinas BioPharma in Q4 2020 and held it in 15 quarters.
  • LPL Financial's Matinas BioPharma position peaked at $394K in Q3 2022.
  • 18 funds tracked by Wall St. Rank held Matinas BioPharma as of Q3 2024.

Based on LPL Financial's 13F filing for Q3 2024, filed 8 Nov 2024.